Fundz

Ikena Oncology reported raising $42.6 Million in an initial SEC Form D filing, from an offering of $42.6 Million

PRIVATEAug 18, 2023

Amount Raised

$42.6 Million

$42.6 Million sold, per SEC Form D (first sale Aug 4, 2023)

Round Type

Venture

BostonBiotechnologyHealth CareMedicalTherapeutics

Quick answer

Ikena Oncology raised $42.6 Million in a funding round, dated August 4, 2023. Ikena Oncology is based in Boston, Massachusetts, United States.

How much did Ikena Oncology raise?
Ikena Oncology raised $42.6 Million in a funding round on August 4, 2023.
What does Ikena Oncology do?
Ikena OncologyTM is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network.
Where is Ikena Oncology based and how big is it?
Ikena Oncology is based in Boston, Massachusetts, United States.
Who are the decision-makers at Ikena Oncology?
Fundz holds 1 contact at Ikena Oncology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Ikena Oncology that raised within 45 days of this round, from Fundz verified event records.

  • Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
  • Aptose Biosciences raised $3M (Seed) on September 6, 2023.
  • Actimed Therapeutics raised $6.1M (Series A) on August 22, 2023.
  • Renibus Therapeutics raised $47M (Funding Round) on July 18, 2023.
  • Actym Therapeutics raised $11M on June 28, 2023.
  • Actimed Therapeutics raised an undisclosed amount (Series A) on June 26, 2023.

Who to call at Ikena Oncology, and when

A new round usually means Ikena Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ikena Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ikena Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ikena Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ikena Oncology

Location

Boston, Massachusetts, United States

About

Ikena OncologyTM is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. The Company’s lead targeted oncology program, IK-930, is a TEAD1 selective Hippo pathway inhibitor, a known tumor suppressor pathway that also drives resistance to multiple targeted therapies. The Company’s additional research spans other targets in the Hippo pathway as well as the RAS signaling pathway, including developing IK-595, a novel MEK-RAF inhibitor. Additionally, IK-175, an AHR antagonist, is being developed in collaboration with Bristol Myers Squibb. Ikena aims to utilize their depth of institutional knowledge and breadth of tools to efficiently develop the right drug using the right modality for the right patient. To learn more, visit www.ikenaoncology.com or follow us on Twitter and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ikena Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Ikena Oncology's next move

See what Strategic adds

Ikena Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.